Ignota Labs addresses this issue by applying deep learning, cheminformatics, and bioinformatics to uncover and resolve the root causes of drug toxicity, unlocking new opportunities for assets that would otherwise be abandoned.
Ignota Labs has raised €6.6M across 1 funding round from 5 investors, most recently a Seed round in Feb 2025. Based in London, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-02-26 | Seed | €6.6M |
| AIX Ventures,Blue Wire Capital,Gaingels,Modi Ventures,Montage Ventures |
| View deal → |
